Cerca e trova il CMO / CDMO di cui hai bisogno
Discover highly skilled partners for your drug development and manufacturing project.
Cenexi Hérouville Saint Clair
Cenexi
Il sito di Hérouville-Saint-Clair, situato vicino a Caen, in Normandia, è specializzato nella produzione e nel riempimento di liquidi sterili iniettabili e non
SOSTANZE CONTROLLATE: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, High potential for abuse & no medical use, Lower potential for abuse
MERCATI: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), ANVISA (Brazil), Russian Health Authorities, MHRA (UK), MFDS (South Korea), TGA (Australia)
REGIONE: Europe
COMPLIANCE: FDA (cGMP), PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), NMPA (Cina GMP), EMA (GMP UE), MHRA (UK GMP), MFDS/KFDA (Repubblica di Corea GMP)
USO: Umano
SERVIZI: Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging
AREE TERAPEUTICHE DI COMPETENZA (ATC): (C) Cardiovascular system, (D) Dermatologicals, (H) Systemic hormonal preparations excl. sex hormones and insulins, (J) Antiinfectives for systemic use, (N) Nervous system, (A) Digestive tract and metabolism
OEB (Occupational Exposure Banding): 4 / HPAPI (PDE = 10 - 100 µg/giorno), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1.000 µg/giorno), 1 / low-hazard (PDE > 10,000 µg/day)
DIMENSIONE DEL LOTTO: Piccolo, Medio
CATEGORIA / PRODOTTO: FDF / DRUG PRODUCTS
Cenexi Laboratoires Thissen
Cenexi
Questo stabilimento di 8.000 m2, con edifici sparsi su un sito di quasi sette ettari, si trova a 20 km a sud di Bruxelles e conta 340 dipendenti*.
OEB (Occupational Exposure Banding): 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/giorno), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1.000 µg/giorno), 1 / low-hazard (PDE > 10,000 µg/day)
BSL (Livello di sicurezza biologica): 3, 4, 1, 2
SOSTANZE CONTROLLATE: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, Lower potential for abuse
MERCATI: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), MHRA (UK), MFDS (South Korea), TGA (Australia)
REGIONE: Europe
COMPLIANCE: FDA (cGMP), PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), TGA (Australia GMP), NMPA (Cina GMP), EMA (GMP UE), Health Canada (Canada GMP), Organizzazione Mondiale della Sanità (GMP / HACCP), MHRA (UK GMP), MFDS/KFDA (Repubblica di Corea GMP)
DIMENSIONE DEL LOTTO: Grande, Piccolo, Medio
USO: Umano, Veterinario
SERVIZI: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging
AREE TERAPEUTICHE DI COMPETENZA (ATC): (H) Systemic hormonal preparations excl. sex hormones and insulins, (L) Antineoplastic and immunomodulating agents, (G) Genito urinary system and sex hormones
CATEGORIA / PRODOTTO: FDF / DRUG PRODUCTS
OEB (Occupational Exposure Banding): 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/giorno)
BSL (Livello di sicurezza biologica): 3, 4
SOSTANZE CONTROLLATE: High potential for abuse & medical use
COMPLIANCE: ICH, ISO, ANVISA (Brazil B-GMP), TITCK (Turkish Health Authorities), SFDA (Saudi Food & Drug Authority), NMPA (Cina GMP), EMA (GMP UE)
MERCATI: EMA (EU), NMPA (China), ANVISA (Brazil), MHRA (UK), SFDA (Saudi Arabia), Turkish Health Authorities
SERVIZI: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging
REGIONE: Europe
DIMENSIONE DEL LOTTO: Grande, Piccolo, Medio
USO: Umano
AREE TERAPEUTICHE DI COMPETENZA (ATC): (L) Antineoplastic and immunomodulating agents
CATEGORIA / PRODOTTO: FDF / DRUG PRODUCTS
CHEMICAL-SYNTHETIC manufacturing site
MAI network supplier
Soluzioni per programmi di distribuzione non virale
Location available after registration
FDF / DRUG PRODUCTS manufacturing site
MAI network supplier
CDMO farmaceutico end-to-end
Location available after registration
SERVICES manufacturing site
MAI network supplier
Fiale liquide e liofilizzate: due suite per camere bianche conformi all'Allegato I BSL-2.
Location available after registration
These facilities match your main criteria but not all optional filters.
Laboratorios Grifols | Murcia Plant
Grifols International
Soluzioni di produzione sterili (piccole molecole) in sacchetti flessibili.
MERCATI: ANMAT (Argentina), ANVISA (Brazil), FDA (USA), EMA (EU), MFDS (South Korea), TGA (Australia)
DIMENSIONE DEL LOTTO: Piccolo, Medio, Grande
CATEGORIA / PRODOTTO: FDF / DRUG PRODUCTS
COMPLIANCE: ISP (Chile BPM), ANMAT (nuove BPF dell'Argentina), EMA (GMP UE), ANVISA (Brazil B-GMP), Organizzazione Mondiale della Sanità (GMP / HACCP), MHRA (UK GMP), TGA (Australia GMP), FDA (cGMP), ECOVADIS, ISO, INVIMA, Health Canada (Canada GMP), MFDS/KFDA (Repubblica di Corea GMP)
SOSTANZE CONTROLLATE: Lowest potential for abuse, Lower potential for abuse, Low potential for abuse
REGIONE: Europe
USO: Umano, Veterinario
SERVIZI: Analytical / QC services, Logistics, Manufacturing services, Packaging, Quality Assurance services
OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day), 3 (PDE = 100 - 1.000 µg/giorno)
AREE TERAPEUTICHE DI COMPETENZA (ATC): (M) Musculoskeletal system, (J) Antiinfectives for systemic use, (C) Cardiovascular system, (A) Digestive tract and metabolism, (N) Nervous system
Adragos Pharma | Halden
Adragos Pharma
Siamo specializzati nella produzione di sacche per flebo, fiale e fiale di plastica utilizzando la tecnologia Blow-Fill-Seal (BFS) e altre forme di dosaggio.
MERCATI: Turkish Health Authorities, EDE (UAE), ANVISA (Brazil), PMDA (Japan), FDA (USA), EMA (EU), MFDS (South Korea), SFDA (Saudi Arabia), TGA (Australia), NMPA (China), MHRA (UK)
DIMENSIONE DEL LOTTO: Piccolo, Medio, Grande
CATEGORIA / PRODOTTO: FDF / DRUG PRODUCTS
COMPLIANCE: EMA (GMP UE), PMDA/MHLW (Japan GMP), UAE Ministry of Health & Prevention, ANVISA (Brazil B-GMP), Organizzazione Mondiale della Sanità (GMP / HACCP), MHRA (UK GMP), TGA (Australia GMP), FDA (cGMP), NSF, NMPA (Cina GMP), ISO, TITCK (Turkish Health Authorities), MFDS/KFDA (Repubblica di Corea GMP)
SOSTANZE CONTROLLATE: Lowest potential for abuse, High potential for abuse & medical use, Lower potential for abuse, Low potential for abuse
REGIONE: Europe
USO: Umano
SERVIZI: Analytical / QC services, Logistics, Manufacturing services, Regulatory services, Packaging, Quality Assurance services
OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day), 3 (PDE = 100 - 1.000 µg/giorno)
AREE TERAPEUTICHE DI COMPETENZA (ATC): (A) Digestive tract and metabolism, (D) Dermatologicals, (V06) Nutrients
Adragos Pharma | Kawagoe
Adragos Pharma
La nostra struttura fornisce la migliore produzione di compresse e fiale.
CATEGORIA / PRODOTTO: FDF / DRUG PRODUCTS, SERVICES
MERCATI: EDE (UAE), PMDA (Japan), FDA (USA), CDSCO (India), EMA (EU), MFDS (South Korea), SFDA (Saudi Arabia), TGA (Australia), NMPA (China), Health Canada (Canada), MHRA (UK)
COMPLIANCE: EMA (GMP UE), PMDA/MHLW (Japan GMP), FDA (cGMP)
DIMENSIONE DEL LOTTO: Grande
SOSTANZE CONTROLLATE: Lowest potential for abuse, High potential for abuse & medical use, Lower potential for abuse, Low potential for abuse
USO: Umano
SERVIZI: Analytical / QC services, Logistics, Manufacturing services, Regulatory services, Packaging, Quality Assurance services
REGIONE: APAC
OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day), 3 (PDE = 100 - 1.000 µg/giorno)
Adragos Pharma | Livron
Adragos Pharma
Produzione di liquidi sterili e supposte. Gestiamo più di 100 molecole, gestione dei narcotici e servizi di analisi e stabilità.
DIMENSIONE DEL LOTTO: Piccolo, Medio, Grande
CATEGORIA / PRODOTTO: FDF / DRUG PRODUCTS
COMPLIANCE: EMA (GMP UE), MFDS/KFDA (Repubblica di Corea GMP)
SOSTANZE CONTROLLATE: Lowest potential for abuse, High potential for abuse & no medical use, High potential for abuse & medical use, Lower potential for abuse, Low potential for abuse
REGIONE: Europe
USO: Umano
SERVIZI: Analytical / QC services, Logistics, Manufacturing services, Regulatory services, Packaging, Quality Assurance services
MERCATI: PMDA (Japan), CDSCO (India), EMA (EU), MFDS (South Korea), TGA (Australia), NMPA (China), MHRA (UK)
OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/giorno), 1 / low-hazard (PDE > 10,000 µg/day), 3 (PDE = 100 - 1.000 µg/giorno)
Green Phoenix Labs GmbH
Green Phoenix Labs GmbH
Azienda di terapia cellulare con capacità di camere bianche in eccesso.
DIMENSIONE DEL LOTTO: Piccolo, Medio
AREE TERAPEUTICHE DI COMPETENZA (ATC): (R) Respiratory system, (M) Musculoskeletal system, (G) Genito urinary system and sex hormones, (C) Cardiovascular system, (A) Digestive tract and metabolism, (D) Dermatologicals, (N) Nervous system, (B) Blood and blood forming organs
CATEGORIA / PRODOTTO: FDF / DRUG PRODUCTS, SERVICES, BIOLOGIA
COMPLIANCE: EMA (GMP UE)
SOSTANZE CONTROLLATE: Lowest potential for abuse, Lower potential for abuse, Low potential for abuse
REGIONE: Europe
USO: Umano
SERVIZI: Logistics, Manufacturing services, Regulatory services, Development services, Packaging, Quality Assurance services
OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day), 3 (PDE = 100 - 1.000 µg/giorno)
BSL (Livello di sicurezza biologica): 1
MERCATI: EMA (EU)
Seda Pharma Development Services
Seda Pharma Development Services Ltd
Seda Pharmaceutical Development Services è specializzata nello sviluppo farmaceutico integrato e nella farmacologia clinica.
MERCATI: DIGEMID (Peru), ANMAT (Argentina), Turkish Health Authorities, EDE (UAE), Rest of World, ANVISA (Brazil), ISP (Chile), PMDA (Japan), FDA (USA), MSPAS (Guatemala), CDSCO (India), Russian Health Authorities, EMA (EU), COFEPRIS (Mexico), MFDS (South Korea), SFDA (Saudi Arabia), TGA (Australia), NMPA (China), Health Canada (Canada), INVIMA (Colombia), MHRA (UK)
DIMENSIONE DEL LOTTO: Piccolo, Medio
CATEGORIA / PRODOTTO: FDF / DRUG PRODUCTS
REGIONE: Europe
USO: Umano
COMPLIANCE: MHRA (UK GMP), ECOVADIS
SERVIZI: Analytical / QC services, Manufacturing services, Regulatory services, Development services, Packaging, Quality Assurance services
OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/giorno), 1 / low-hazard (PDE > 10,000 µg/day), 3 (PDE = 100 - 1.000 µg/giorno)
AREE TERAPEUTICHE DI COMPETENZA (ATC): (M) Musculoskeletal system, (G) Genito urinary system and sex hormones, (C) Cardiovascular system, (A) Digestive tract and metabolism, (D) Dermatologicals, (N) Nervous system, (B) Blood and blood forming organs
More facilities on the network
Register to unlock the full catalog with contact details and locations.
+19 more facilities
Create free account